Effective January 24, 2022, the FDA updated the Emergency Use Authorization (EUA) fact sheets for two COVID-19 monoclonal antibody treatments: bamlanivimab plus etesevimab (Eli Lilly) and casirivimab plus imdevimab (Regeneron, also known as REGEN-COV). Neither of these treatments are authorized for use anywhere in the U.S. due to their ineffectiveness against the dominant Omicron variant. Sites are directed to immediately stop administering these therapeutics as they do not retain EUA.

Ph: (443) 281-9157

Fax: (410) 582-8728

801 Landmark Dr.
Glen Burnie, MD 21061
Contact Us

Mon-Fri: 8:30AM-6:30PM

Sat: 9:00AM-2:00PM
Contact Us
Have a question or need assistance? We’re always here to help, we can not wait to hear from you.

Get help by phone

For any questions related to your medications, account issues, or prescription notification preferences, please contact us at (443) 281-9157

Visit us on Facebook

We are available on social media. Stay updated with news and events from our pharmacy. Be sure to like our Facebook page here.

Contact us online

Need to contact us via e-mail? Fill out the form below and we will contact you. Please allow 24-48 hours for a response. For more quicker responses please call us directly.

Pharmacy Address

Soleil Pharmacy
801 Landmark Dr,
Glen Burnie, MD 21061
Map

Pharmacy Phone

Phone: (443) 281-9157
Fax: (410) 582-8728
}

Pharmacy Hours

Mon-Fri: : 8:30am-6:30pm
Sat: : 9am-2pm
Sunday: :Closed